Loading…
Oscar Health, Inc. is projected to rise to $34.11 by 2027, a +55% move from its current price of $21.99. OSCR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $21.28 | $22.02 | $22.78 | +0.13% |
| May 30 | $21.01 | $22.05 | $23.14 | +0.27% |
| May 31 | $20.81 | $22.08 | $23.42 | +0.40% |
| Jun 1 | $20.65 | $22.11 | $23.67 | +0.53% |
| Jun 2 | $20.51 | $22.14 | $23.89 | +0.67% |
| Jun 3 | $20.39 | $22.17 | $24.10 | +0.80% |
| Jun 4 | $20.28 | $22.20 | $24.29 | +0.93% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.28 | $22.20 | $24.29 | +0.93% |
| Week 2 | $19.72 | $22.40 | $25.45 | +1.87% |
| Week 3 | $19.34 | $22.61 | $26.43 | +2.82% |
| Week 4 | $19.06 | $22.82 | $27.33 | +3.78% |
| Week 5 | $18.83 | $23.03 | $28.18 | +4.75% |
| Week 6 | $18.64 | $23.25 | $29.00 | +5.73% |
| Week 7 | $18.49 | $23.47 | $29.79 | +6.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oscar Health, Inc. is a healthcare technology company operating in the United States. It offers health plans to individuals, families, employees, and small group markets.
It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc.
and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Oscar Health, Inc. trades as OSCR and operates as a healthcare technology company in the United States.
The current price is $22.64 with a market capitalization of $6.83B, and its market rank is 1129.
The price outlook presented in the available forecast shows a path of upside, starting at a 2026 average of $22.64 and rising toward multi-decade highs by 2050, with bullish sentiment attaching to most years after 2026. The forecast projects a 2027 average of $36.23, a 2040 average of $156.49, and a 2050 average of $252.32, with progressively higher maximums along the way.
A major floor 50.7% below — a decisive break under it would weaken the trend.
The nearest floor, 29.1% below — buyers have tended to step in here.
The nearest ceiling, 15.1% above — a clean break opens room to run.
A major ceiling 39.5% above — clearing it would confirm fresh momentum.
Key OSCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OSCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.42 | Sell | $22.43 | Sell |
| MA 10 | $23.20 | Sell | $22.46 | Sell |
| MA 20 | $21.56 | Buy | $21.38 | Buy |
| MA 50 | $17.08 | Buy | $18.62 | Buy |
| MA 100 | $15.79 | Buy | $17.07 | Buy |
| MA 200 | $16.60 | Buy | $16.42 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.30 | Neutral |
| Stoch RSI (14) | 1.52 | Buy |
| CCI (20) | 15.18 | Neutral |
| Williams %R (14) | -74.72 | Info |
| MACD (12,26,9) | -0.32 | Sell |
| ROC (12) | 3.19 | Buy |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 25.28 | Neutral |
| TRIX (15) | 1.64 | Buy |
| Awesome (5,34) | 3.14 | Buy |
| Ultimate (7,14,28) | 49.52 | Neutral |
| Momentum (10) | -1.74 | Sell |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 21.62 | Buy |
| ADX (14) | 43.78 | Buy |
| ATR (14) | 0.67 | Info |
The near-term technical posture is bullish overall. RSI(14) is 60, indicating steady positive momentum.
The stock trades above recent support levels, with the 50-day simple moving average at $16.74 and the 200-day simple moving average at $16.53.
Key technical levels show support at $15.29 and resistance at $25.30, while the 30-day price range spans from $17.91 to $28.62.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.85 | $21.99 | $32.59 | 0% | Neutral | |
| $26.40 | $34.11 | $47.05 | +55% | Bullish | |
| $29.91 | $40.01 | $57.61 | +82% | Bullish | |
| $32.18 | $44.34 | $66.04 | +102% | Bullish | |
| $32.22 | $45.57 | $69.83 | +107% | Bullish | |
| $33.44 | $48.45 | $76.10 | +120% | Bullish | |
| $37.82 | $56.04 | $90.01 | +155% | Bullish | |
| $44.79 | $67.80 | $111.11 | +208% | Bullish | |
| $52.93 | $81.78 | $136.52 | +272% | Bullish | |
| $54.31 | $85.58 | $145.33 | +289% | Bullish | |
| $83.02 | $143.22 | $261.19 | +551% | Bullish | |
| $114.55 | $232.30 | $469.58 | +956% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $10.85 | $21.99 | $25.98 | +0.00% |
| June 2026 | $19.85 | $23.44 | $28.43 | +6.59% |
| July 2026 | $20.80 | $24.82 | $30.60 | +5.88% |
| August 2026 | $20.58 | $24.76 | $30.92 | -0.24% |
| September 2026 | $20.61 | $24.97 | $31.51 | +0.87% |
| October 2026 | $21.37 | $26.05 | $33.18 | +4.32% |
| November 2026 | $21.22 | $26.02 | $33.42 | -0.11% |
| December 2026 | $20.43 | $25.19 | $32.59 | -3.21% |
Click any year to see its month-by-month OSCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Oscar Health, Inc.'s 2026 outlook centres on $21.99, within a $10.85 to $32.59 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, OSCR could reach as high as $47.05, with a base case around $34.11 and support toward $26.40 — roughly +55% from $21.99. Buyers look set to stay in control over this stretch.
Expect OSCR to range from $29.91 to $57.61 through 2028. The $40.01 average target implies a +82% move from current prices. That is up +17% on the projected 2027 average. Momentum favours further upside here.
The OSCR price prediction for 2029 points to an average of $44.34 (low $32.18, high $66.04) — a potential gain of +102% on today's $21.99. Buyers look set to stay in control over this stretch.
In 2030, OSCR is projected to trade between $32.22 and $69.83, averaging $45.57 — a potential gain of +107% from today's $21.99. That is up +3% on the projected 2029 average. Momentum favours further upside here.
Oscar Health, Inc.'s 2031 outlook centres on $48.45, within a $33.44 to $76.10 range. That is up +6% on the projected 2030 average. That marks a +120% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, OSCR could reach as high as $90.01, with a base case around $56.04 and support toward $37.82 — roughly +155% from $21.99. Momentum favours further upside here.
Expect OSCR to range from $44.79 to $111.11 through 2033. The $67.80 average target implies a +208% move from current prices. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The OSCR price prediction for 2034 points to an average of $81.78 (low $52.93, high $136.52) — a potential gain of +272% on today's $21.99. Momentum favours further upside here.
In 2035, OSCR is projected to trade between $54.31 and $145.33, averaging $85.58 — a potential gain of +289% from today's $21.99. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Oscar Health, Inc.'s 2040 outlook centres on $143.22, within a $83.02 to $261.19 range. That is up +67% on the projected 2035 average. That marks a +551% change versus current levels. Momentum favours further upside here.
By 2050, OSCR could reach as high as $469.58, with a base case around $232.30 and support toward $114.55 — roughly +956% from $21.99. Buyers look set to stay in control over this stretch.
Investing $1,000 in OSCR today (≈ 45.475216 OSCR) could be worth
$10,563.73
+$9,563.73 (+956%) by 2050 · US Dollar
Based on the average projected OSCR price of $232.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OSCRwould be worth at today's price.
$1,000 invested in OSCR on May 27, 2025 (≈ 66.622251 OSCR) would be worth
$1,465.02
+$465.02 (+46.5%) today · 1.47× · US Dollar
Based on a OSCR entry price of $15.01 vs. today's $21.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $23.42 | $938.94 | -6.1% |
| 1 month ago | $17.18 | $1,279.98 | +28.0% |
| 3 months ago | $13.66 | $1,609.81 | +61.0% |
| 6 months ago | $17.97 | $1,223.71 | +22.4% |
| 1 year ago | $15.01 | $1,465.02 | +46.5% |
| All time (5.0y) ago | $25.3 | $869.17 | -13.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OSCR forecast.
Our base-case forecast reaches $44.00 around 2029.
Implied market cap at $44.00: $11.7B
The multi-year forecast shows ongoing bullish sentiment from 2027 onward. The 2026 average is $22.64 with a 0% ROI, followed by a rising trajectory: 2027 average $36.23, 2028 $42.03, 2029 $46.66, and 2030 $48.44, with a 114% ROI. The outlook continues to strengthen through the 2030s, with 2031 average $51.00 and 2032 $59.94, reaching 2033 at $73.56 and 2034 at $87.65, then 2035 at $92.40.
By 2040, the average climbs to $156.49 with a 591.2% ROI, and by 2050 the average is $252.32 with a 1014.5% ROI, underscoring substantial estimated upside under this scenario. Throughout the horizon, the sentiment remains bullish, with 2040 and 2050 carrying the highest forecasted averages and gains. These figures are estimates and not guarantees; they reflect market-forecasted potential rather than assured outcomes.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $48.44, with a minimum of $33.90 and a maximum of $75.04, and an estimated ROI of 114%. The sentiment for 2030 is bullish.
The long-term forecast is bullish from 2027 onward, with rising averages from $36.23 in 2027 to $252.32 by 2050 and an ROI reaching 1014.5%. The 2026 forecast is neutral, and these are estimates, not guarantees.
Yes. The forecast shows annual highs that exceed $100 in multiple years, with a 2033 max of $122.10 and a 2040 max of $289.88, and a 2050 max of $519.43.
The current price is $22.64 and the market capitalization is $6.83B. The asset ranks 1129 by market capitalization.
The 30-day range is from a low of $17.91 to a high of $28.62.
Oscar Health, Inc. Community Discussion
0Share your Oscar Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.